1. World Health Organization. Depressive disorder (depression). Geneva: World Health Organization; 2023.
2. Korea Disease Control and Prevention Agency. Korea health statistics 2020: Korea national health and nutrition examination survey (KNHANES VIII-2). Cheongju: Korea Disease Control and Prevention Agency; 2022.
3. Fried EI, Epskamp S, Nesse RM, Tuerlinckx F, Borsboom D. What are ‘good’ depression symptoms? Comparing the centrality of DSM and non-DSM symptoms of depression in a network analysis. J Affect Disord 2016;189:314–320.
5. Kennis M, Gerritsen L, van Dalen M, Williams A, Cuijpers P, Bockting C. Prospective biomarkers of major depressive disorder: a systematic review and meta-analysis. Mol Psychiatry 2020;25:321–338.
8. Pariante CM, Lightman SL. The HPA axis in major depression: classical theories and new developments. Trends Neurosci 2008;31:464–468.
9. Modell S, Yassouridis A, Huber J, Holsboer F. Corticosteroid receptor function is decreased in depressed patients. Neuroendocrinology 1997;65:216–222.
10. Bhagwagar Z, Hafizi S, Cowen PJ. Increased salivary cortisol after waking in depression. Psychopharmacology (Berl) 2005;182:54–57.
11. Pariante CM. The glucocorticoid receptor: part of the solution or part of the problem? J Psychopharmacol 2006;20(4 Suppl):79–84.
12. Bremmer MA, Deeg DJ, Beekman AT, Penninx BW, Lips P, Hoogendijk WJ. Major depression in late life is associated with both hypo- and hypercortisolemia. Biol Psychiatry 2007;62:479–486.
13. Stetler C, Miller GE. Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research. Psychosom Med 2011;73:114–126.
14. Fries E, Dettenborn L, Kirschbaum C. The cortisol awakening response (CAR): facts and future directions. Int J Psychophysiol 2009;72:67–73.
15. Clow A, Hucklebridge F, Stalder T, Evans P, Thorn L. The cortisol awakening response: more than a measure of HPA axis function. Neurosci Biobehav Rev 2010;35:97–103.
16. Clow A, Hucklebridge F, Thorn L. The cortisol awakening response in context. Int Rev Neurobiol 2010;93:153–175.
17. Chida Y, Steptoe A. Cortisol awakening response and psychosocial factors: a systematic review and meta-analysis. Biol Psychol 2009;80:265–278.
18. Veen G, van Vliet IM, DeRijk RH, Giltay EJ, van Pelt J, Zitman FG. Basal cortisol levels in relation to dimensions and DSM-IV categories of depression and anxiety. Psychiatry Res 2011;185:121–128.
19. Vreeburg SA, Hoogendijk WJ, DeRijk RH, van Dyck R, Smit JH, Zitman FG, et al. Salivary cortisol levels and the 2-year course of depressive and anxiety disorders. Psychoneuroendocrinology 2013;38:1494–1502.
20. Beck AT, Steer RA, Carbin MG. Psychometric properties of the Beck depression inventory: twenty-five years of evaluation. Clin Psychol Rev 1988;8:77–100.
21. Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, et al. The 16-item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry 2003;54:573–583.
22. Giano Z, Ernst CW, Snider K, Davis A, O’Neil AM, Hubach RD. ACE domains and depression: investigating which specific domains are associated with depression in adulthood. Child Abuse Negl 2021;122:105335
23. Marganska A, Gallagher M, Miranda R. Adult attachment, emotion dysregulation, and symptoms of depression and generalized anxiety disorder. Am J Orthopsychiatry 2013;83:131–141.
24. Fischer-Kern M, Tmej A. Mentalization and depression: theoretical concepts, treatment approaches and empirical studies–an overview. Z Psychosom Med Psychother 2019;65:162–177.
25. Waugh CE, Koster EH. A resilience framework for promoting stable remission from depression. Clin Psychol Rev 2015;41:49–60.
26. Lee JY, Choi SW, Jang SA, Ryu JS, Shin HK, Sim JY, et al. Development of the battery test for screening of depression and mental health: PROtective and Vulnerable factors battEry Test (PROVE). J Korean Neuropsychiatr Assoc 2021;60:143–157.
27. Reivich K, Shatté A. The resilience factor: 7 essential skills for overcoming life’s inevitable obstacles. Portland: Broadway Books; 2002.
28. Kim J. Resilience. Seoul: Wisdomhouse; 2019.
29. Shin WY, Kim MG, Kim JH. Developing measures of resilience for Korean adolescents and testing cross, convergent, and discriminant validity. Stud Korean Youth 2009;20:105–131.
30. Goodyer IM, Park RJ, Netherton CM, Herbert J. Possible role of cortisol and dehydroepiandrosterone in human development and psychopathology. Br J Psychiatry 2001;179:243–249.
31. Hong JP, Park SJ, Park S, Lim A, Jeon D. Reliability and validity study of the Korean self rating version of quick inventory of depressive symptomatology (K-QIDS-SR). Mood Emot 2013;11:44–50.
32. Yi JS, Bae SO, Ahn YM, Park DB, Noh KS, Shin HK, et al. Validity and reliability of the Korean version of the Hamilton depression rating scale (K-HDRS). J Korean Neuropsychiatr Assoc 2005;44:456–465.
33. Lee SH, Shin C, Kim H, Jeon SW, Yoon HK, Ko YH, et al. Validation of the Korean version of the generalized anxiety disorder 7 self-rating scale. Asia Pac Psychiatry 2022;14:e12421
34. Lee J, Shin C, Ko YH, Lim J, Joe SH, Kim S, et al. The reliability and validity studies of the Korean version of the perceived stress scale. Korean J Psychom Med 2012;20:127–134.
37. Hardeveld F, Spijker J, Vreeburg SA, Graaf RD, Hendriks SM, Licht CM, et al. Increased cortisol awakening response was associated with time to recurrence of major depressive disorder. Psychoneuroendocrinology 2014;50:62–71.
38. Gold PW, Chrousos GP. Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/ NE states. Mol Psychiatry 2002;7:254–275.
39. Stewart JW, Quitkin FM, McGrath PJ, Klein DF. Defining the boundaries of atypical depression: evidence from the HPA axis supports course of illness distinctions. J Affect Disord 2005;86:161–167.
40. Parker G, Roy K, Mitchell P, Wilhelm K, Malhi G, Hadzi-Pavlovic D. Atypical depression: a reappraisal. Am J Psychiatry 2002;159:1470–1479.
41. O’Keane V, Frodl T, Dinan TG. A review of atypical depression in relation to the course of depression and changes in HPA axis organization. Psychoneuroendocrinology 2012;37:1589–1599.
42. Meinlschmidt G, Heim C. Decreased cortisol awakening response after early loss experience. Psychoneuroendocrinology 2005;30:568–576.
44. Iob E, Baldwin JR, Plomin R, Steptoe A. Adverse childhood experiences, daytime salivary cortisol, and depressive symptoms in early adulthood: a longitudinal genetically informed twin study. Transl Psychiatry 2021;11:420
45. Fogelman N, Canli T. Early life stress and cortisol: a meta-analysis. Horm Behav 2018;98:63–76.
46. Dorn LD, Lucke JF, Loucks TL, Berga SL. Salivary cortisol reflects serum cortisol: analysis of circadian profiles. Ann Clin Biochem 2007;44(Pt 3):281–284.
47. Gozansky WS, Lynn JS, Laudenslager ML, Kohrt WM. Salivary cortisol determined by enzyme immunoassay is preferable to serum total cortisol for assessment of dynamic hypothalamic–pituitary–adrenal axis activity. Clin Endocrinol (Oxf) 2005;63:336–341.